Study title:
Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida - Ferrara P, D'Aleo CM, Tarquini E, Salvatore S, Salvaggio E - BJU International - 2001; 87:674-677Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida - Ferrara P, D'Aleo CM, Tarquini E, Salvatore S, Salvaggio E - BJU International - 2001; 87:674-677
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Urigenital diseases C12 and C13
|
Brands: |
MAH holders: Please see report, Please see report |
Assessment: |
Active substance: OXITRIPTAN |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number: N/A
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|